Tudor Investment Corporation »

Sionna Therapeutics shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Sionna Therapeutics (SION) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Sionna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sionna Therapeutics held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sionna Therapeutics by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2026-06-30 $993k 23k 43.99

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
Taiwan Semiconductor Manufacturing Co Ltd - US Depository Receipt (TSM)
Spdr Gold Shares - US ETP ETF Option Call Option (GLD)
Nvidia Corp - US Equity (NVDA)
Micron Technology Inc - US Equity (MU)
Microsoft Corp - US Equity (MSFT)
Ishares Core S&P 500 Etf - US ETP ETF Option Call Option (IVV)
Tesla Inc - US Equity (TSLA)
Ishares Iboxx High Yield Corporate Bond Etf - US E ETF Option Put Option (HYG)
State Street Energy Select Sector SPDR ETF - US ET ETF Option Call Option (XLE)
State Street Financial Select Sector SPDR ETF - US ETF Option Call Option (XLF)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Advanced Micro Devices Inc - US Equity (AMD)
Amazon.Com Inc - US Equity (AMZN)

View all positions for Tudor Investment Corporation

Top funds holding Sionna Therapeutics

RA Capital Management
Tpg Gp A
Viking Global Investors
Atlas Venture Life Science Advisors
OrbiMed Advisors
Enavate Sciences GP
Adage Capital Partners GP
Jpmorgan Chase & Co
BlackRock
Jennison Associates
Citadel Advisors
Vanguard Capital Management
Perceptive Advisors
T. Rowe Price Associates
State Street Corporation

View all funds holding Sionna Therapeutics